The ULTRASUR project treats tumors using focused ultrasound. The techniques for the treatment of tumors using high-intensity focused ultrasound (HIFU) are developing rapidly. This technique is fast and not highly invasive, and there are often fewer side-effects than with other techniques – surgery, radiotherapy, brachytherapy, chemotherapy etc.
The Imasonic Company has developed unique expertise in this field. ULTRASUR is sponsored by the companies Imasonic, C&K Components and the laboratories of FEMTO-ST. It will be used to develop sources of high-intensity focused ultrasound for tumor treatment systems. The project focuses in particular on studying the effects of ageing of materials and structures under conditions of high acoustic stress. Industrial applications will be experimented with. 

MEDICALIP: the cytomegalovirus can be diagnosed earlier! Infection of newborn babies with the cytomegalovirus can lead to the late onset of clinical symptoms and serious neurological and sensory problems. A method for the fast and straightforward diagnosis of newborn babies would be a major advance compared with the techniques used today.
This is the aim of the MEDICALIP project which has been set up to study the manufacturing and performance of embedded microsystems designed to diagnose infection. In addition, the project aims to reduce the quantity of biological fluid required for diagnosis.
The Optics Department of Professor Duffieux from the FEMTO-ST Institute, the University Hospitals of Besançon and Dijon, a unit from the French Medical Research Council in Toulouse and the two companies Statice Santé and Alcis are participating in the project.

BRAIN PET: This project involves developing high-performance positron emission tomography (PET) designed for the functional exploration of the brain. The production of compact devices combining PET and MRI at a reduced cost with millimetric resolution is a considerable advance in the field of brain imaging. Tumor detection will be a hundred times better!
The project is sponsored by Besançon University Hospital. 

VALVELEC, a new implantable valve: the aim of this project, sponsored by Sophysa in partnership with the CEA, Sensirion, Pi and Silmach, is to design a new type of implantable valve for treating normal pressure hydrocephalus. The valve will also be more reliable and easier to program.

CONTRULTIME improves the safety of the ultimate pre-transfusion check at the patient's bed.. The concept of objectifying the ultimate pre-transfusion check at the patient's bed is designed to make the check fully secure. This new "smart blood transfusion system" is based on an innovative concept both for producing the hemagglutination reaction and interpreting it in situ, in real-time, without handling or human intervention.
The project is sponsored by the PM Duffieux Optics Laboratory, Besançon University Hospital and the French Blood Agency. The project should lead to inter-company collaboration. 

The aim of EMERGENCE is to design a detector of cancerous cells in melanomas (skin cancer). The principle of detection is based on fluorescence: this is a sufficiently reliable parameter to discriminate a cell in a healthy environment from a cell that is part of a cancerous group.
Sponsors: FEMTO-ST and the Cancer Cluster

Studies are underway to design a passive flotation sensor. This should allow the creation of a platform that will be used by the genetics and reproduction team of Besançon University Hospital to characterize ovum membrane elasticity.
Sponsors: Besançon University Hospital, the Laboratoire d’Automatique of FEMTO-ST, the ENSMM and the Institute of Intelligent Systems and Robotics at the Université Pierre et Marie Curie in Paris.

The UTBM has a unique electrical engineering platform in France, the principle of which is to work on complete systems promoting the development of a wheelchair capable of identifying and avoiding obstacles in its path, leading to greater independence and safety.
Through the integration of wireless communication technologies, using international cellular networks, the location of the wheelchair is always known. The information collected can be transmitted and a warning message automatically sent to a pre-recorded number.
Through an integrated GPS card, the wheelchair can guide itself automatically along a route sent by a PDA. The wheelchair is also fuel cell-powered.